Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Radiotherapy and Sorafenib in Patients With Hepatoma

NCT01319942 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT01319942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
Lead sponsor
China Medical University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2010
Completion date
June 30, 2013
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma